Search Results Within Category "Arthritis & Rheumatic Diseases "
Geniculate Artery Embolization
In this clinical research study, the goal is to learn more about geniculate artery embolization (GAE) treatment. Embolization is a procedure where doctors block the blood vessels to certain areas of the body to stop blood flow to that area. In this research study, the geniculate artery in the knee will be blocked with a goal to decrease pain, stiffness, and difficulty performing daily activities caused by knee osteoarthritis. After gathering data on outcomes and safety from this small study, we will determine if a larger study will be reasonable.
Deb Mailand - mailand@umn.edu
• osteoarthritis of the one knee with symptoms that have not improved after at least 3 months of treatment such as PT, injection, medications,
• partial knee replacement and total knee arthroplasty are not currently options (may be in the future)
• 40-70 years of age
• weight greater than 250 pounds
• smoke or have smoked tobacco regularly (smoking 1 or more tobacco product(s) per week) within the last year
• diabetic with A1C greater than 9%
• advanced peripheral arterial disease
Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
The primary objective for this observational study is to collect general and medical data from children, adolescents, and young adults who had pediatric onset rheumatic disease. This data will be used to evaluate the long-term safety and efficacy of therapeutic agents used to treat these diseases. This information will allow investigators to accurately report and follow changes in current medication use patterns and compare these to proposed standards and current treatment recommendations. The use of a single registry will allow for more analysis of the different therapeutic agents by allowing them to be compared to each other.
Colleen Correll - corr0250@umn.edu
• diagnosed with rheumatic disease prior to age 16 years for juvenile idiopathic arthritis (JIA)
• onset prior to age 19 years for all other rheumatic diseases
• younger than 21 years